[go: up one dir, main page]

WO2018236128A3 - Infectious norovirus screening method - Google Patents

Infectious norovirus screening method Download PDF

Info

Publication number
WO2018236128A3
WO2018236128A3 PCT/KR2018/006914 KR2018006914W WO2018236128A3 WO 2018236128 A3 WO2018236128 A3 WO 2018236128A3 KR 2018006914 W KR2018006914 W KR 2018006914W WO 2018236128 A3 WO2018236128 A3 WO 2018236128A3
Authority
WO
WIPO (PCT)
Prior art keywords
screening method
norovirus
infectious norovirus
infectious
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2018/006914
Other languages
French (fr)
Korean (ko)
Other versions
WO2018236128A2 (en
Inventor
김두운
김송학
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Foundation of Chonnam National University
Original Assignee
Industry Foundation of Chonnam National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Foundation of Chonnam National University filed Critical Industry Foundation of Chonnam National University
Publication of WO2018236128A2 publication Critical patent/WO2018236128A2/en
Publication of WO2018236128A3 publication Critical patent/WO2018236128A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

본 발명은 감염형 노로바이러스의 선별 방법을 제공한다. 본 발명은 실험실 내에서의 노로바이러스 감염 및 질병 발생 간의 관련성에 대한 연구를 가능하게 한다.The present invention provides a method of screening for an infectious strain of norovirus. The present invention enables the study of the relationship between norovirus infection and disease outbreaks in the laboratory.

PCT/KR2018/006914 2017-06-19 2018-06-19 Selection method of infectious type Norovirus Ceased WO2018236128A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0077476 2017-06-19
KR1020170077476A KR101966525B1 (en) 2017-06-19 2017-06-19 Method for Distincting Infectious Norovirus

Publications (2)

Publication Number Publication Date
WO2018236128A2 WO2018236128A2 (en) 2018-12-27
WO2018236128A3 true WO2018236128A3 (en) 2019-02-14

Family

ID=64737287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/006914 Ceased WO2018236128A2 (en) 2017-06-19 2018-06-19 Selection method of infectious type Norovirus

Country Status (2)

Country Link
KR (1) KR101966525B1 (en)
WO (1) WO2018236128A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280806A1 (en) * 2010-05-17 2013-10-24 Donald Rubin Mammalian genes involved in infection
US20140315750A1 (en) * 2011-11-15 2014-10-23 The United States Of America, As Represented By The Secretary, Department Of Health Selective detection of norovirus
US20160102136A1 (en) * 2013-05-09 2016-04-14 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Single-domain vhh antibodies directed to norovirus gi.1 and gii.4 and their use
KR20160133067A (en) * 2015-05-11 2016-11-22 전남대학교산학협력단 Methods for Distincting Infections Virus based on Molecular Biomarker and Neutralizing Virus Generating Food Poisoning

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280806A1 (en) * 2010-05-17 2013-10-24 Donald Rubin Mammalian genes involved in infection
US20140315750A1 (en) * 2011-11-15 2014-10-23 The United States Of America, As Represented By The Secretary, Department Of Health Selective detection of norovirus
US20160102136A1 (en) * 2013-05-09 2016-04-14 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Single-domain vhh antibodies directed to norovirus gi.1 and gii.4 and their use
KR20160133067A (en) * 2015-05-11 2016-11-22 전남대학교산학협력단 Methods for Distincting Infections Virus based on Molecular Biomarker and Neutralizing Virus Generating Food Poisoning

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VASHIST, SURENDER ET AL.: "Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses", JOURNAL OF VIROLOGY, vol. 89, no. 12, 2015, pages 6352 - 6363, XP055572537 *

Also Published As

Publication number Publication date
WO2018236128A2 (en) 2018-12-27
KR101966525B1 (en) 2019-04-08
KR20180138244A (en) 2018-12-31

Similar Documents

Publication Publication Date Title
DK3746568T3 (en) CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS
EP3897523A4 (en) MICROCAPSULES PREPARED FROM PROTEIN
HUE057559T2 (en) Antibodies against PD-1 and their applications
EP3904937A4 (en) MICROSCOPE SYSTEM
DK3551753T3 (en) DIAGNOSTICS BASED ON CRISPR EFFECTOR SYSTEM
HUE062927T2 (en) Anti-TIGIT antibodies and their application procedures
HUE058975T2 (en) Antibodies against CD73 and their applications
HUE056677T2 (en) Anti-tim-3 antibodies and preparations
EP3602122A4 (en) LIDAR SMALL FORM FACTOR SENSOR SYSTEM
HUE053737T2 (en) Pyridopyrroloquinoxaline compounds, their preparations and their uses
EP3655872A4 (en) MANUFACTURING DESIGN MODIFICATION SYSTEM
JP2019046670A5 (en)
TR201810635T4 (en) Anti-jagged1 antibodies and methods of use.
EP3565564A4 (en) HIV IMMUNOTHERAPY WITHOUT PRE-IMMUNIZATION STEP
JP2017137500A5 (en)
HUE055886T2 (en) Insect trap and procedure for its application
EP3614076A4 (en) THERMODYNAMIC CYCLE SYSTEM
EP3475167A4 (en) OFFSET ARRANGEMENT
JP2018054415A5 (en)
EP3436590A4 (en) TRANSFERING RNA (TSRNA)
EP3835007A4 (en) ROBOT SYSTEM
JP2019011568A5 (en)
EP3859233A4 (en) MULTI-STAGE COMPRESSION SYSTEM
EP3751266A4 (en) SPECIMEN
EP3859234A4 (en) MULTI-STAGE COMPRESSION SYSTEM

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18820921

Country of ref document: EP

Kind code of ref document: A2